Lunai Bioworks files amended suit alleging 29.6 million failed-deliver shares

The Nasdaq-listed company says defendants used naked short selling from November 2025 through May 2026 and is seeking treble damages under the federal RICO statute.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.